| 臺大學術典藏 |
2021-05-06T01:53:10Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang C.-T.; YEE-CHUN CHEN; Lin S.-F.; Shau W.-Y.; Liu C.-J.; Sheng W.-H.; Wang J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-06-24T07:16:08Z |
Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ?3 Months to <18 Years with Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial
|
Bradley J.S.;Roilides E.;Broadhurst H.;Cheng K.;Li-Min Huang;Mascasullo V.;Newell P.;Stone G.G.;Tawadrous M.;Wajsbrot D.;Yates K.;Gardner A.; Bradley J.S.; Roilides E.; Broadhurst H.; Cheng K.; LI-MIN HUANG; Mascasullo V.; Newell P.; Stone G.G.; Tawadrous M.; Wajsbrot D.; Yates K.; Gardner A. |
| 臺大學術典藏 |
2022-03-28T02:45:56Z |
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial
|
Schoser B.; Roberts M.; Byrne B.J.; Sitaraman S.; Jiang H.; Lafor?t P.; Toscano A.; Castelli J.; D?az-Manera J.; Goldman M.; van der Ploeg A.T.; Bratkovic D.; Kuchipudi S.; Mozaffar T.; Kishnani P.S.; Sebok A.; Pestronk A.; Dominovic-Kovacevic A.; Khan A.; Koritnik B.; Tard C.; Lindberg C.; Quinn C.; Eldridge C.; Bodkin C.; Reyes-Leiva D.; Hughes D.; Stefanescu E.; SALORT-CAMPANA E.; Butler E.; Bouhour F.; Kim G.; Konstantinos Papadimas G.; Parenti G.; Bartosik-Psujek H.; Kushlaf H.; Akihiro H.; Lau H.; Pedro H.; Andersen H.; Amartino H.; Shiraishi H.; Kobayashi H.; Tarnev I.; Vengoechea J.; Avelar J.; Shin J.-H.; Cauci J.; Alonso-P?rez J.; Janszky J.; Berthy J.; Cornelia K.; Gutschmidt K.; Claeys K.; Judit Molnar M.; Wencel M.; Tarnopolsky M.; Dimachkie M.; Tchan M.; Freimer M.; Longo N.; Vidal-Fernandez N.; Musumeci O.; Goker-Alpan O.; Deegan P.; Clemens P.R.; Roxburgh R.; Henderson R.; Hopkin R.; Sacconi S.; Fecarotta S.; Attarian S.; Wenninger S.; Dearmey S.; Hiwot T.; Burrow T.; Ruck T.; Sawada T.; Laszlo V.; L?scher W.; YIN-HSIU CHIEN; PROPEL Study Group |
| 國立臺灣大學 |
2012 |
Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections
|
Lai, Chung-Chih; Sheng, Wang-Huei; Wang, Jann-Tay; Liao, Chun-Hsin; Ho, Mao-Wang; Chen, Chwen-Je; Chen, Der-Li; Chou, Ming-Uen; Lee, Chien-Ming; Lin, Yee-Chun; Pong, Ming-Ye; Chang, Shan-Chwen; 張上淳 |
| 臺大學術典藏 |
2021-02-26T02:00:01Z |
Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections
|
Lai C.-C.; WANG-HUEI SHENG; Wang J.-T.; Liao C.-H.; Ho M.-W.; Chen C.-J.; Chen D.-L.; Chou M.-U.; Lee C.-M.; Lin Y.-C.; Pong M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2022-05-13T08:04:50Z |
Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections
|
Lai C.-C.; Sheng W.-H.; JANN-TAY WANG; Liao C.-H.; Ho M.-W.; Chen C.-J.; Chen D.-L.; Chou M.-U.; Lee C.-M.; Lin Y.-C.; Pong M.-Y.; Chang S.-C. |
| 國立成功大學 |
2019 |
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection
|
Wei, L.;Kumada, H.;Perumalswami, Perumalswami P.V.;Tanwandee, Tanwandee T.;Cheng, W.;Heo, J.;Cheng, P.-N.;Hwang, P.;Mu, S.M.;Zhao, X.M.;Asante-Appiah, E.;Caro, L.;Hanna, G.J.;Robertson, M.N.;Haber, B.A.;Talwani, R. |
| 臺大學術典藏 |
2022-05-14T23:35:54Z |
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
|
NI-CHUNG LEE; YIN-HSIU CHIEN; Wang, Chung Hsing; Wong, Siew Lee; STEVEN SHINN-FORNG PENG; Tsai, Fuu Jen; WUH-LIANG HWU |
| 臺大學術典藏 |
2022-05-17T06:03:52Z |
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
|
NI-CHUNG LEE; YIN-HSIU CHIEN; Wang, Chung Hsing; Wong, Siew Lee; STEVEN SHINN-FORNG PENG; Tsai, Fuu Jen; WUH-LIANG HWU |
| 臺大學術典藏 |
2022-09-06T02:56:09Z |
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
|
Lee N.-C.; YIN-HSIU CHIEN; Wang C.-H.; Wong S.-L.; Peng S.S.-F.; Tsai F.-J.; Hwu W.-L. |
